Skip to content
HowShorted

Flexion Therapeutics Inc short interest in 2019

In 2019, Flexion Therapeutics Inc's disclosed short interest ran from 22.53% of shares outstanding on 15 Jan 2019 to 20.00% on 31 Dec 2019, a change of -2.53 percentage points. The year's high was 23.61% on 31 Jul 2019 and its low 18.25% on 29 Nov 2019, averaging 21.73% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 20.84 days on 28 Feb 2019. Full history: Flexion Therapeutics Inc.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021

Aggregate net short position time series for Flexion Therapeutics Inc in 2019

2019 in figures

Start of year
22.53% (15 Jan 2019)
End of year
20.00% (31 Dec 2019)
Change
-2.53 pp
High
23.61% (31 Jul 2019)
Low
18.25% (29 Nov 2019)
Average
21.73%
Highest days to cover
20.84 (28 Feb 2019)
SEC filings marked
10

Every report in 2019

Flexion Therapeutics Inc short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 201922.53%9.32results (8-K), results (8-K)
31 Jan 201922.53%12.65
15 Feb 201921.67%17.47
28 Feb 201922.29%20.8410-K filed, results (8-K)
15 Mar 201922.35%10.98
29 Mar 201921.42%11.92
15 Apr 201921.58%10.02
30 Apr 201922.07%17.97
15 May 201921.42%10.3410-Q filed, results (8-K)
31 May 201919.84%13.46
14 Jun 201919.49%18.92
28 Jun 201920.84%13.33
15 Jul 201922.64%18.10
31 Jul 201923.61%15.91
15 Aug 201922.95%10.3010-Q filed, results (8-K)
30 Aug 201923.53%17.45
13 Sep 201923.21%14.80
30 Sep 201922.35%14.39
15 Oct 201923.30%15.52
31 Oct 201923.36%16.04
15 Nov 201920.72%12.3010-Q filed, results (8-K)
29 Nov 201918.25%11.22
13 Dec 201919.50%8.27
31 Dec 201920.00%5.19

See also: Flexion Therapeutics Inc's full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.